http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2132027-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e5de4b0cc9df1b26842f37d5e85b2fce
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-225
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-22
filingDate 1997-07-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1eaf6557cf98e7cbe840b15ec6306495
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_089b3808abb9ac5dcf8e92e1295e4513
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5f7aeb4f76003ae0ca42ea1dfdee8208
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_986527be92dcd31c5840f1eefd16841a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0856636b8ecf60d39dbad86d74f98d34
publicationDate 1999-08-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber ES-2132027-A1
titleOfInvention DEVELOPMENT OF AN ARTIFICIAL SKIN THROUGH KERATINOCIT CULTIVATION ON A BASIS OF FIBRIN AND HUMAN FIBROBLASTES AND METHOD OF PREPARATION OF THIS SKIN FOR TRANSPLANTING.
abstract Development of an artificial skin by culturing keratinocytes on a fibrin base and human fibroblasts and method of preparing this skin for transplantation. Artificial skin obtained by cell culture of keratinocytes on a base consisting of a human fibrin gel populated with human fibroblasts. This base allows very rapid development of keratinocytes, detecting proteins from the dermal-epidermal junction in this artificial skin that facilitate subsequent transplant success. This artificial skin requires, to be used in the clinic, a previous preparation that consists of fixing it to a solid support and a system that enables transport to the transplant site without breaking it. The artificial skin described here can be used for the treatment of major burns, chronic skin ulcers or used, through the use of genetically modified cells, as a basis for gene therapy.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9168125-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7449333-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006123004-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03035115-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2311469-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9173906-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8323638-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7879605-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03002154-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7700351-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1545565-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2173812-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013016836-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2165678-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7244552-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8679475-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2184623-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-02072800-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8137965-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1545565-A1
priorityDate 1997-07-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0485210-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0526550-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5326356-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9633750-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID439199
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415966231

Total number of triples: 43.